Teladoc Health (TDOC) Liabilities and Shareholders Equity (2014 - 2026)

Teladoc Health has disclosed Liabilities and Shareholders Equity across 13 years of filings, most recently posting $2.8 billion for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $2.8 billion, down 18.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.4 billion (down 18.38% YoY), and the FY2025 annual result was $2.9 billion, down 18.72% from the prior year.
• Liabilities and Shareholders Equity came in at $2.8 billion for Q1 2026 at Teladoc Health, down from $2.9 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $11.1 billion in Q1 2022 to a low of $2.8 billion in Q1 2026.
• The 5-year median for Liabilities and Shareholders Equity is $4.3 billion (2023), against an average of $4.6 billion.
• Across the five-year window, Liabilities and Shareholders Equity sank 75.5% in 2022 and advanced 1.08% in 2023, its largest moves.
• Teladoc Health's Liabilities and Shareholders Equity stood at $4.3 billion in 2022, then climbed by 1.08% to $4.4 billion in 2023, then fell by 19.94% to $3.5 billion in 2024, then slipped by 18.72% to $2.9 billion in 2025, then retreated by 1.79% to $2.8 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $2.8 billion (Q1 2026), $2.9 billion (Q4 2025), and $2.9 billion (Q3 2025), per Business Quant data.